ATE108664T1 - Verfahren zur verhütung von gvhd. - Google Patents

Verfahren zur verhütung von gvhd.

Info

Publication number
ATE108664T1
ATE108664T1 AT88311471T AT88311471T ATE108664T1 AT E108664 T1 ATE108664 T1 AT E108664T1 AT 88311471 T AT88311471 T AT 88311471T AT 88311471 T AT88311471 T AT 88311471T AT E108664 T1 ATE108664 T1 AT E108664T1
Authority
AT
Austria
Prior art keywords
methods
prevent gvhd
gvhd
prevent
man
Prior art date
Application number
AT88311471T
Other languages
English (en)
Inventor
Thomas A Reichert
Richard Champlin
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE108664T1 publication Critical patent/ATE108664T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT88311471T 1987-12-02 1988-12-02 Verfahren zur verhütung von gvhd. ATE108664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12773687A 1987-12-02 1987-12-02

Publications (1)

Publication Number Publication Date
ATE108664T1 true ATE108664T1 (de) 1994-08-15

Family

ID=22431675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88311471T ATE108664T1 (de) 1987-12-02 1988-12-02 Verfahren zur verhütung von gvhd.

Country Status (5)

Country Link
EP (1) EP0319333B1 (de)
JP (1) JPH0653684B2 (de)
AT (1) ATE108664T1 (de)
DE (1) DE3850750T2 (de)
ES (1) ES2059539T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT60768A (en) 1990-03-16 1992-10-28 Sandoz Ag Process for producing cd25 fixing molecules
GB2280439B (en) * 1992-03-11 1995-11-22 Xenova Ltd CD4 binding agents and inhibitors of collagenase and protein kinase C
JPH10158192A (ja) * 1996-10-03 1998-06-16 Eisai Co Ltd 移植片対宿主疾患（ｇｖｈｄ）の治療および臓器移植時の移植片拒絶反応抑制のための医薬組成物
JP5688734B2 (ja) * 2008-12-12 2015-03-25 国立大学法人 東京大学 移植片対腫瘍効果を保存した免疫学的再構築促進剤または感染症予防剤
EP2471543A1 (de) * 2010-12-02 2012-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520226A (en) * 1982-07-19 1985-05-28 The United States Of America As Represented By The Department Of Health And Human Services Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies

Also Published As

Publication number Publication date
JPH0653684B2 (ja) 1994-07-20
JPH01172345A (ja) 1989-07-07
ES2059539T3 (es) 1994-11-16
EP0319333A3 (en) 1990-03-28
DE3850750D1 (de) 1994-08-25
EP0319333A2 (de) 1989-06-07
DE3850750T2 (de) 1994-12-22
EP0319333B1 (de) 1994-07-20

Similar Documents

Publication Publication Date Title
DE3876273D1 (de) Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens.
JPS5778867A (en) Artificial kidney and method of purifying blood by using artificial kidney
DE3865869D1 (de) Kohlenstoffhaltiges sorbentmittel zur trennung von pyrogenen und dessen verwendung zur erzeugung von reinem wasser.
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
DE58906363D1 (de) Verfahren zur Überführung von festen, weitgehend wasserfreien Abfallstoffen in Glasform sowie Vorrichtung zur Durchführung des Verfahrens.
EP0094575A3 (en) Methods and materials for treatment of disease states involving immunological factors
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DK98187A (da) Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma
ATA205288A (de) Verfahren zur gemeinsamen vergasung von fluessigen und festen, staubfoermigen brennstoffen
EP0209543A4 (de) Peptidfragmente menschlicher apolipoproteine, typspezifische antikörper und verwendungsverfahren.
PL247999A1 (en) Method of obtaining proteinous concentrates and nutrients from animal blood
EP0131627A4 (de) Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikörper und verfahren zu ihrer verwendung.
ATE108664T1 (de) Verfahren zur verhütung von gvhd.
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE3861297D1 (de) Verfahren zur reinigung und entsorgung von russ- und aschehaltigen abwaessern.
KR960001503B1 (en) Method for rdetecting antibodies to human immunodeficiency virus
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
ZA879621B (en) Method for the determination of anti-p.falciparum sporozoite antibodies in human blood
ATE88924T1 (de) Verfahren zur entsorgung von kuechenabfaellen.
BG37380A3 (en) Method for preparing 1, 1- dioxo- 6- halo (or 6, 6- dihalo)- penicillanoyloxymethylic ester of 6- (2- amino- 2- phenylacetamido) penicillanic acid
AT386545B (de) Verfahren zum reinigen von gasen sowie vorrichtung zur durchfuehrung dieses verfahrens
DE3874445D1 (de) Verfahren zur herstellung von schalentierextrakt-konzentraten und schalentierextrakt-konzentrate.
FR2605184B1 (fr) Nouveau micro-organisme et procede de culture l'utilisant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee